Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
Bedics G, Egyed B, Kotmayer L, Benard-Slagter A, de Groot K, Bekő A, Hegyi LL, Bátai B, Krizsán S, Kriván G, Erdélyi DJ, Müller J, Haltrich I, Kajtár B, Pajor L, Vojcek Á, Ottóffy G, Ujfalusi A, Szegedi I, Tiszlavicz LG, Bartyik K, Csanádi K, Péter G, Simon R, Hauser P, Kelemen Á, Sebestyén E, Jakab Z, Matolcsy A, Kiss C, Kovács G, Savola S, Bödör C, Alpár D. Bedics G, et al. Among authors: bodor c. Br J Cancer. 2023 Aug;129(3):455-465. doi: 10.1038/s41416-023-02309-8. Epub 2023 Jun 21. Br J Cancer. 2023. PMID: 37340093 Free PMC article.
EZH2 Y641 mutations in follicular lymphoma.
Bödör C, O'Riain C, Wrench D, Matthews J, Iyengar S, Tayyib H, Calaminici M, Clear A, Iqbal S, Quentmeier H, Drexler HG, Montoto S, Lister AT, Gribben JG, Matolcsy A, Fitzgibbon J. Bödör C, et al. Leukemia. 2011 Apr;25(4):726-9. doi: 10.1038/leu.2010.311. Epub 2011 Jan 14. Leukemia. 2011. PMID: 21233829 No abstract available.
Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Seraihi AF, Richter J, Bernhart SH, Efeyan A, Iqbal S, Matthews J, Clear A, Guerra-Assunção JA, Bödör C, Quentmeier H, Mansbridge C, Johnson P, Davies A, Strefford JC, Packham G, Barrans S, Jack A, Du MQ, Calaminici M, Lister TA, Auer R, Montoto S, Gribben JG, Siebert R, Chelala C, Zoncu R, Sabatini DM, Fitzgibbon J. Okosun J, et al. Among authors: bodor c. Nat Genet. 2016 May 27;48(6):700. doi: 10.1038/ng0616-700b. Nat Genet. 2016. PMID: 27230687 No abstract available.
In vitro functional characterization of biosimilar therapeutic antibodies.
Láng JA, Balogh ZC, Nyitrai MF, Juhász C, Gilicze AKB, Iliás A, Zólyomi Z, Bodor C, Rábai E. Láng JA, et al. Among authors: bodor c. Drug Discov Today Technol. 2020 Dec;37:41-50. doi: 10.1016/j.ddtec.2020.11.010. Epub 2020 Dec 11. Drug Discov Today Technol. 2020. PMID: 34895654 Review.
Myelodysplastic syndrome: 2011 and beyond.
Okosun J, Bödör C, Smith M. Okosun J, et al. Among authors: bodor c. Br J Nurs. 2011 Dec 8-2012 Jan 11;20(22):1434. doi: 10.12968/bjon.2011.20.22.1434. Br J Nurs. 2011. PMID: 22241492 No abstract available.
[Chronic myelogenous leukemia: diagnosis and treatment].
Demeter J, Poros A, Bödör C, Horváth L, Masszi T. Demeter J, et al. Among authors: bodor c. Orv Hetil. 2016 Sep;157(37):1459-68. doi: 10.1556/650.2016.30521. Orv Hetil. 2016. PMID: 27615196 Hungarian.
134 results